SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-031455
Filing Date
2024-03-14
Accepted
2024-03-14 16:08:51
Documents
5
Effectiveness Date
2024-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 glue-s8-2024.htm S-8 91423
2 EX-5.1 glue-ex5_1.htm EX-5.1 12557
3 EX-23.1 glue-ex23_1.htm EX-23.1 2715
4 EX-FILING FEES glue-exfiling_fees.htm EX-FILING FEES 25231
5 GRAPHIC img200495983_0.jpg GRAPHIC 26389
  Complete submission text file 0000950170-24-031455.txt   169502
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277929 | Film No.: 24750151
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)